Can mirtazapine be used to treat anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mirtazapine for Anxiety Treatment

Mirtazapine is effective for treating anxiety and can be used as a therapeutic option, particularly when anxiety co-occurs with depression, sleep disturbances, or in patients with cardiovascular disease. 1, 2

Efficacy for Anxiety

  • Mirtazapine has demonstrated efficacy for treating depression with accompanying anxiety symptoms, with moderate strength of evidence according to the American College of Physicians 2
  • It shows beneficial anxiolytic effects that can appear early in treatment, making it suitable for patients requiring prompt symptom relief 3
  • Mirtazapine has shown effectiveness in various anxiety disorders including post-traumatic stress disorder, panic disorder, and social anxiety disorder, though larger trials are needed to confirm these findings 4

Clinical Advantages in Anxiety Treatment

Rapid Onset of Action

  • Mirtazapine demonstrates a statistically significantly faster onset of action compared to SSRIs (citalopram, fluoxetine, paroxetine, sertraline), which is beneficial for patients requiring rapid symptom relief 2
  • Improvement in anxiety symptoms can be noted after the first week of therapy with continued improvement over subsequent weeks 5

Sleep Benefits

  • Particularly useful for patients with anxiety accompanied by insomnia due to its beneficial effects on sleep disturbances 2, 6
  • The sedative effects are most pronounced at lower doses (15mg) due to its antihistaminic (H1) activity 3

Safety in Special Populations

  • Mirtazapine has been shown to be safe in patients with cardiovascular disease, making it a suitable option for treating anxiety in this population 1
  • It can be used for sleep disturbances in patients with end-stage cardiovascular disease when cognitive behavioral therapy for insomnia is not effective 1

Dosing and Administration

  • The recommended starting dosage is 15 mg/day administered as a single dose at bedtime 6
  • Can be titrated up to 45 mg/day based on clinical response 5
  • Sedative effects are often more pronounced at lower doses (15mg) and may decrease at higher doses 3

Efficacy in Treatment-Resistant Cases

  • In treatment-resistant depression with severe generalized anxiety, adding mirtazapine to SSRI/SNRI therapy showed significant improvements in anxiety symptoms compared to placebo 7
  • Patients with severe anxiety (GAD-7 ≥ 16) receiving mirtazapine had significantly lower anxiety scores at 12 weeks compared to placebo 7

Side Effect Considerations

  • Most common adverse effects include somnolence, increased appetite, weight gain, and dizziness 6, 3
  • Unlike SSRIs, mirtazapine does not appear to be associated with sexual dysfunction 3
  • Somnolence, the most commonly reported side effect, appears to be less frequent at higher dosages 3

Clinical Decision Algorithm

  1. First-line consideration: Use mirtazapine when anxiety co-occurs with:

    • Depression with insomnia 2, 3
    • Cardiovascular disease 1
    • Need for rapid symptom relief 2, 5
  2. Alternative use: Consider mirtazapine when:

    • SSRIs/SNRIs have failed or are poorly tolerated 7
    • Sexual dysfunction is a concern with other antidepressants 3
    • Weight gain would be beneficial (e.g., in patients with poor appetite) 6
  3. Caution/monitoring needed:

    • Monitor for sedation, especially at initiation and with lower doses 3
    • Watch for weight gain due to increased appetite 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mirtazapine Efficacy and Properties

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Mirtazapine, an antidepressant.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.